N. Yalman Et Al. , "Fludarabine, cytarabine, G-CSF and idarubicin (FLAG-IDA) for the treatment of relapsed or poor risk childhood acute leukemia.," The Turkish journal of pediatrics , vol.42, pp.198-204, 2000
Yalman, N. Et Al. 2000. Fludarabine, cytarabine, G-CSF and idarubicin (FLAG-IDA) for the treatment of relapsed or poor risk childhood acute leukemia.. The Turkish journal of pediatrics , vol.42 , 198-204.
Yalman, N., Sarper, N., Devecioğlu, O., Anak, S., Eryilmaz, E., Can, M., ... Yenilmez, H.(2000). Fludarabine, cytarabine, G-CSF and idarubicin (FLAG-IDA) for the treatment of relapsed or poor risk childhood acute leukemia.. The Turkish journal of pediatrics , vol.42, 198-204.
Yalman, N Et Al. "Fludarabine, cytarabine, G-CSF and idarubicin (FLAG-IDA) for the treatment of relapsed or poor risk childhood acute leukemia.," The Turkish journal of pediatrics , vol.42, 198-204, 2000
Yalman, N Et Al. "Fludarabine, cytarabine, G-CSF and idarubicin (FLAG-IDA) for the treatment of relapsed or poor risk childhood acute leukemia.." The Turkish journal of pediatrics , vol.42, pp.198-204, 2000
Yalman, N. Et Al. (2000) . "Fludarabine, cytarabine, G-CSF and idarubicin (FLAG-IDA) for the treatment of relapsed or poor risk childhood acute leukemia.." The Turkish journal of pediatrics , vol.42, pp.198-204.
@article{article, author={N Yalman Et Al. }, title={Fludarabine, cytarabine, G-CSF and idarubicin (FLAG-IDA) for the treatment of relapsed or poor risk childhood acute leukemia.}, journal={The Turkish journal of pediatrics}, year=2000, pages={198-204} }